These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Non-seminomatous germ cell tumours of the testis: game and set but not match. Thomson DB; Walpole ET; Grimes D Aust N Z J Med; 1991 Dec; 21(6):835-6. PubMed ID: 1726357 [No Abstract] [Full Text] [Related]
7. Alternating combination chemotherapy in patients with extragonadal germ cell tumors. A Southwest Oncology Group study. Bukowski RM; Wolf M; Kulander BG; Montie J; Crawford ED; Blumenstein B Cancer; 1993 Apr; 71(8):2631-8. PubMed ID: 7680950 [TBL] [Abstract][Full Text] [Related]
9. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy. Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521 [TBL] [Abstract][Full Text] [Related]
11. Lowered Cisplatin Dose and No Bleomycin in the Treatment of Pediatric Germ Cell Tumors: Results of the GCT-99 Protocol From the Brazilian Germ Cell Pediatric Oncology Cooperative Group. Lopes LF; Macedo CR; Aguiar Sdos S; Barreto JH; Martins GE; Sonaglio V; Milone M; Lima ER; Almeida MT; Lopes PM; Watanabe FM; D'Andrea ML; Pianovski MA; Melaragno R; Vianna SM; Moreira ME; Bruniera P; de Oliveira CZ J Clin Oncol; 2016 Feb; 34(6):603-10. PubMed ID: 26729441 [TBL] [Abstract][Full Text] [Related]
12. Chemotherapy of germ-cell ovarian tumours: first-line treatment with etoposide, bleomycin and cisplatin or carboplatin. Smales E; Peckham MJ Eur J Cancer Clin Oncol; 1987 May; 23(5):469-74. PubMed ID: 2443358 [TBL] [Abstract][Full Text] [Related]
13. Is high-dose chemotherapy after primary chemotherapy a therapeutic option for patients with primary mediastinal nonseminomatous germ cell tumor? Banna GL; De Giorgi U; Ferrari B; Castagna L; Alloisio M; Marangolo M; Rosti G; Santoro A Biol Blood Marrow Transplant; 2006 Oct; 12(10):1085-91. PubMed ID: 17084372 [TBL] [Abstract][Full Text] [Related]
15. [A case of mediastinal non seminomatous germ cell tumor successfully treated with chemotherapy and curative surgery]. Watanabe A; Sasaki A; Iwaki H; Nakashima S; Abe T Kyobu Geka; 2000 Nov; 53(12):1052-4. PubMed ID: 11079315 [TBL] [Abstract][Full Text] [Related]
16. Paclitaxel+BEP (T-BEP) regimen as induction chemotherapy in poor prognosis patients with nonseminomatous germ cell tumors: a phase II study. Tryakin A; Fedyanin M; Kanagavel D; Fainstein I; Sergeev J; Polockij B; Matveev V; Zakharova T; Garin A; Tjulandin S Urology; 2011 Sep; 78(3):620-5. PubMed ID: 21764427 [TBL] [Abstract][Full Text] [Related]
17. Development of angiosarcoma in a mediastinal non-seminomatous germ cell tumor that exhibited growing teratoma syndrome during chemotherapy. Matsuoka S; Koyama T; Takeda T; Yamada K; Hyogotani A; Hamanaka K; Sekiguchi N; Koizumi T Thorac Cancer; 2019 Jan; 10(1):111-115. PubMed ID: 30407736 [TBL] [Abstract][Full Text] [Related]
18. Etoposide, cisplatin, bleomycin, and cyclophosphamide (ECBC) as first-line chemotherapy for poor-risk non-seminomatous germ cell tumors. Gerl A; Clemm C; Hentrich M; Hartenstein R; Wilmanns W Acta Oncol; 1993; 32(5):541-6. PubMed ID: 7692901 [TBL] [Abstract][Full Text] [Related]
19. Bleomycin, etoposide, and cisplatin for three cycles compared with etoposide and cisplatin for four cycles in good-risk germ cell tumors: is there a preferred regimen? Einhorn LH; Foster RS J Clin Oncol; 2006 Jun; 24(16):2597-8; author reply 2598-9. PubMed ID: 16735718 [No Abstract] [Full Text] [Related]